Hiska L. van der Weide

Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis

Myra E. van Linde, Cyrillo G. Brahm, Philip C. De Witt Hamer et al. · Journal of Neuro-Oncology · 2017 · 201 citations · Full text

Medicine, Neurosurgery, Oncology +16

Tumor Volume Combined With Number of Positive Lymph Node Stations Is a More Important Prognostic Factor Than TNM Stage for Survival of Non–Small-Cell Lung Cancer Patients Treated With (Chemo)radiotherapy

Cary Oberije, Dirk De Ruysscher, Hiska L. van der Weide et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 125 citations

Medicine, Oncology, Surgery +12

Development and External Validation of Prognostic Model for 2-Year Survival of Non–Small-Cell Lung Cancer Patients Treated With Chemoradiotherapy

Cary Oberije, Shipeng Yu, Dirk De Ruysscher et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 117 citations

Medicine, Oncology, Radiation Oncology +14

Development and Validation of a Prognostic Model Using Blood Biomarker Information for Prediction of Survival of Non–Small-Cell Lung Cancer Patients Treated With Combined Chemotherapy and Radiation or Radiotherapy Alone (NCT00181519, NCT00573040, and NCT00572325)

Cary Oberije, Hugo J.W.L. Aerts, Shipeng Yu et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 74 citations · Full text

Medicine, Oncology, Radiation Oncology +14

FDG–PET–CT reduces the interobserver variability in rectal tumor delineation

Jeroen Buijsen, Jørgen van den Bogaard, Hiska L. van der Weide et al. · Radiotherapy and Oncology · 2012 · 64 citations · Full text

Medicine, Nuclear Medicine, Radiology +16